Illumina to Complete Analysis of Ovarian Cancer Set by End of Q1; Move to Validation Phase

Early results indicate that the genomes analyzed so far are "highly rearranged," even though they were derived from early-stage tumors, and that there is "a lot of heterogeneity" between them.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.